Education
About Us
Working with TipRanks
Follow Us
Ian Frazer Insider Profile
4 Followers
Ian Frazer, Director at Microba Life Sciences Limited, holds 2.67M shares in Microba Life Sciences Limited (Ticker: AU:MAP). Most recently, Ian Frazer Bought 833,333 shares of Microba Life Sciences Limited on Aug 15, 2025 for an estimated value of AU$75.00K.
Ian Frazer Microba Life Sciences Limited (MAP)Director
Microba Life Sciences Limited (MAP)
Director
Ranked #68,099 out of 103,225 Corporate Insiders
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-9.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Ian Frazer holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 08, 2022 - Nov 08, 2023
Return:+27.20%
The most profitable trade made by Ian Frazer
Ian Frazer's Trading History
List of latest transactions for each holding click on a transaction to see Ian Frazer's performance on stock
You May Also Like
Ian Frazer insider profile FAQ
What is the percentage of profitable transactions made by Ian Frazer?
The percentage of profitable transactions made by Ian Frazer is 40%.
What is the average return per transaction made by Ian Frazer?
The average return per transaction made by Ian Frazer is -9.30%.
What stocks does Ian Frazer hold?
Ian Frazer holds: AU:MAP stocks.
What was Ian Frazer’s latest transaction?
Ian Frazer latest transaction was an Informative Buy of AU$75.00K.
What was Ian Frazer's most profitable transaction?
Ian Frazer’s most profitable transaction was an Informative Buy of AU:MAP stock on November 8, 2022. The return on the trade was 27.20%.
What is Ian Frazer's role in Microba Life Sciences Limited?
Ian Frazer's role in Microba Life Sciences Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.